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Giacomo Clerici,3,4 MD, Maria Grazia Modena,2 MD,
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Background: The concomitant use of femoral and popliteal accesses has been recom-
mended for challenging superficial femoral artery (SFA) occlusions, but no comprehen-
sive comparison of this approach to a strategy of femoral access only is available. We
thus aimed to appraise the risk-benefit balance of retrograde popliteal access as
bail-out strategy for SFA occlusions. Methods: Consecutive patients with symptomatic
SFA occlusion and undergoing percutaneous revascularization were enrolled. We distin-
guished patients in whom retrograde popliteal access was required as bail-out strategy
versus those not requiring such access. The primary end-point was procedural success.
Results: A total of 130 patients (152 limbs) were included, with 23 patients (25 limbs)
requiring retrograde popliteal access. Occlusion length was 20.6 6 8.8 cm in those
requiring popliteal access versus 18.5 6 8.5 cm in those without popliteal access, with
TASC C/D lesions in 23 (92%) versus 106 (83%). Procedural success was achieved in 92
out of 107 patients (86.0%) treated with a standard approach and 22 out of 23 patients
(95.7%) treated with retrograde popliteal access (total 114 out of 130 [87.7%]) and
112 out of 127 limbs (88.2%) and 24 out of 25 limbs (96.0%), respectively (total 136 out of
152 [89.5%]). No significant increase in early or long-term adverse events was associated
with retrograde popliteal access. Conclusions: Whenever standard access sites do not
enable successful recanalization of SFA occlusions, retrograde popliteal access can be
safely and effectively envisioned as bail-out strategy. VC 2012 Wiley Periodicals, Inc.
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INTRODUCTION
The burden of peripheral artery disease is increasing
due to worldwide increases in life expectancy, obesity,
and diabetes [1]. Symptomatic lower limb atherosclerosis
most commonly involves the superficial femoral artery
(SFA), with complex lesions and occlusions commonly
and diffusely involving this thigh vessel. Although
surgical bypass grafting is still considered the best
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management strategy for symptomatic atherosclerotic
SFA disease, it remains associated with morbidity [1,2].
Endovascular therapy has seen major improvements
in the last decades with the introduction of several
dedicated techniques (e.g., subintimal angioplasty) [3]
and devices (e.g., re-entry devices and stents) [3,4].
This has led to favorable clinical outcomes that closely
match those of surgical therapy, especially in patients
with critical limb ischemia [2]. However, success rates
of endovascular treatment for SFA occlusions remain
suboptimal, especially due to problems in re-entry after
extensive subintimal tracking of guidewires [2–4].
Retrograde popliteal access has been proposed as a
safe and effective means to increase success rate of
percutaneous transluminal angioplasty (PTA) for SFA
occlusions, after failed antegrade attempt by means of
ipsilateral or contralateral femoral (or occasionally
brachial or axillary) access [5,6]. The rationale for this
increased success rate is that the distal occlusion stump
in this vessel as well as in others is usually tapered,
thereby increasing the likelihood of intraluminal seat-
ing of guidewires [7–9]. However, only few studies
have been reported, without systematic comparison to
a standard (i.e., femoral or brachial) approach [5,6,10–
18].
Hypothesizing that retrograde popliteal approach is
safe and effective when employed as a bail-out strategy,
we appraised the risk-benefit balance of bail-out retro-
grade popliteal access as strategy for SFA occlusions in
the setting of a multicenter retrospective study.
METHODS
Study Design and Patient Population
This study was based on a dedicated electronic data
capturing system. Given the observational design, insti-
tutional review board approval was waived.
Consecutive patients with symptomatic lower limb
ischemia and angiographic evidence of total occlusion
of the SFA were included in case endovascular treat-
ment of the SFA occlusion was attempted. All patients
provided written informed consent.
Procedures
Percutaneous transluminal angioplasty was first
attempted by means of ipsilateral or contralateral femo-
ral access, or occasionally by means of brachial
approach, with the decision for this ‘‘default’’ access at
the operator’s discretion. Standard and subintimal
angioplasty techniques were employed for SFA recana-
lization, using 0.03500, 0.01800, and 0.01400 guidewires,
both nonhydrophilic and hydrophilic, supported by
hydrophilic catheters or compatible balloons. If intralu-
minal or subintimal angioplasty was successful,
stenting was performed with self-expandable stents in
case of significant residual stenosis or flow-limiting
dissection after balloon-only intervention.
In case of failure of femoral access only PTA, retro-
grade popliteal access was attempted at the operator’s
discretion. In general, all cases in which the popliteal
artery was free of significant disease for at least
40 mm were considered suitable for retrograde popli-
teal access. Conversely, diffuse significant atheroscler-
otic involvement or dissection of the popliteal artery
were considered contraindications to popliteal access.
Retrograde popliteal access was attempted in all cases
during the index procedure, to exploit the combined
femoral and popliteal accesses according to the con-
trolled antegrade and retrograde subintimal tracking
technique (CART)/subintimal arterial flossing with
antegrade-retrograde intervention (SAFARI) [15,19].
In case popliteal access was attempted, the patient
was turned in a prone position, and the popliteal artery
was punctured under angiographic guidance with a 18G
needle, enabling the deployment of a 4Fr 11 cm sheath
(Cordis, Miami, FL). Through the sheath, 0.03500, 0.01800,
and 0.01400 guidewires, both nonhydrophilic and hydro-
philic, were advanced retrogradely supported by hydro-
philic catheters or compatible balloons. In case of subin-
timal tracking, care was taken to ensure true lumen re-
entry not more proximally than the SFA ostium to avoid
jeopardizing the profunda femoris artery. If intraluminal
or subintimal angioplasty was successful by the retro-
grade route, a wire was deployed either antegradely from
the femoral access or retrogradely from the popliteal
access and the procedure completed with additional bal-
loon dilations and self-expandable stenting in case of sig-
nificant residual stenosis or flow-limiting dissection after
balloon-only intervention. In case of inability to cross
the occlusion or to intraluminal re-entry by both femoral
and popliteal route, no further attempt was conducted
and the procedure was interrupted. Hemostasis at the
femoral access was achieved by either manual compres-
sion or closure devices, whereas hemostasis at the popli-
teal or brachial accesses was managed with manual com-
pression only in all cases, with compression typically
lasting 3 minutes for each sheath French [20].
All patients were pretreated or loaded peri-procedur-
ally with aspirin and clopidogrel, with discharge dual
antiplatelet therapy for 1 month in all patients under-
going PTA. Peri-procedural anticoagulation was based
on weight-adjusted (70 IU/Kg) unfractioned heparin
aiming to achieve an activated clotting time >250 s.
After discharge, patients were followed clinically and
by means of duplex ultrasound, with repeat angiogra-
phy in case of symptoms or imaging evidence of reste-
nosis.
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Definitions and End-points
The primary end-point of the study was the rate of
procedural success, defined as angiographic success
(<20% diameter stenosis without flow-limiting dissec-
tion) in the absence of in-hospital death, bypass
surgery, acute limb ischemia requiring thrombolysis or
other interventions, and thrombolysis in myocardial in-
farction major bleeding of a femoral only access versus
a femoral plus popliteal access. Other end-points
included the occurrence of significant (>5 cm) groin
hematoma, rehospitalization, amputation, and primary
patency, defined as lack of significant (>50%) resteno-
sis or occlusion at follow-up imaging (e.g., duplex
ultrasound), with repeat angiography being performed
only in patients with recurrent symptoms or requiring
staged procedures.
Statistical Analysis
Categorical variables are reported as n (%) and were
compared with the chi-squared or Fisher exact tests.
Continuous variables are reported as mean  standard
deviation and were compared with Student t test. A
two-tailed P value of 0.05 was considered statistically
significant. All calculations were performed with SPSS
18 (IBM, Armonk, NY).
RESULTS
Baseline and Lesion Characteristics
A total of 130 patients were included, treated on 152
limbs (Table I). Of these, 107 (82%) patients (127
[84%] limbs) were treated with standard access sites
without attempting retrograde popliteal access, in com-
parison to 23 (18%) patients (25 [16%] limbs), which
required retrograde popliteal access. Specifically, femo-
ral access, either antegrade or retrograde, was per-
formed in all cases but one. This patient was treated
by means of brachial access, as he had previously been
treated with kissing stenting in both common iliac
arteries and both antegrade ipsilateral and retrograde
contralateral femoral access were unfeasible. Diabetes
TABLE I. Baseline Characteristics
Standard access
(patients ¼ 107;
limbs ¼ 127)
Retrograde
popliteal access
(patients ¼ 23;
limbs ¼ 25) P value
Male gender 76 (71%) 19 (83%) 0.256
Age (years) 71  10 71  10 0.955
Prior myocardial infarction 32 (30%) 9 (39%) 0.404
Prior coronary artery
bypass grafting
24 (22%) 3 (13%) 0.405
Prior percutaneous
transluminal angioplasty
27 (26%) 5 (22%) 0.707
Prior lower limb bypass
grafting
13 (12%) 0 0.123
Hypertension 49 (46%) 19 (83%) 0.001
Dyslipidemia 32 (30%) 10 (44%) 0.207
Cigarette smoking 0.076
Former 29 (27%) 3 (13%)
Current 11 (10%) 6 (26%)
Family history of
cardiovascular
disease
14 (13%) 3 (13%) 1.0
Chronic renal failure 15 (14%) 1 (4%) 0.302
Diabetes mellitus 0.120
Noninsulin dependent 22 (21%) 9 (39%)
Insulin dependent 53 (50%) 7 (30%)
Baseline Fontaine class 0.500
I 18 (14%) 4 (16%)
II 44 (35%) 7 (28%)
III 3 (2%) 2 (8%)
IV 63 (50%) 12 (48%)
TABLE II. Lesion and Procedural Data
Standard access
(patients ¼ 107;
limbs ¼ 127)
Retrograde
popliteal access
(patients ¼ 23;
limbs ¼ 25) P value
Prior percutaneous
transluminal angioplasty
on target vessel
27 (21%) 1 (4%) 0.048
Prior stenting on target
vessel
12 (9%) 2 (8%) 1.0
Occlusion length (cm) 18.5  8.5 20.6  8.8 0.498
Severe calcification 11 (18%) 4 (25%) 0.495
TASC type C/D 106 (83%) 23 (92%) 0.371
Default access site 0.901
Antegrade ipsilateral
femoral
16 (13%) 3 (12%)
Retrograde contralateral
femoral
110 (86%) 22 (88%)
Brachial access 1 (1%) 0
Default access
sheath size (Fr)
0.070
4 59 (47%) 6 (24%)
6 or more 68 (53%) 19 (76%)
Default access
sheath length (cm)
<0.001
11 85 (67%) 6 (24%)
15 1 (1%) 0
45 or more 40 (32%) 19 (76%)
Popliteal access
sheath size (Fr)
–
4 – 25 (100%)
6 or more – 0
Popliteal access
sheath length (cm)
–
11 – 25 (100%)
Good distal run-off 46 (73%) 8 (53%) 0.211
Balloon diameter (mm) 5.5  0.9 5.8  0.7 0.130
Balloon pressure (ATM) 12.4  3.4 11.6  2.3 0.349
Balloon length (mm) 109  53 102  44 0.539
Stent implantation 46 (40%) 13 (59%) 0.098
Stent diameter (mm) 6.4  0.9 6.4  0.5 0.936
Total stent length (mm) 158  75 143  76 0.540
Post-procedural
diameter stenosis (%)
17  34 8  21 0.091
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mellitus was highly prevalent in both groups, respec-
tively, in 75 (71%) versus 16 (69%), and critical limb
ischemia was reported as admission diagnosis in 66
(52%) versus 14 (56%).
Most occlusions were long and complex (Table II),
with lesion length of 18.5  8.5 cm versus 20.6  8.8
cm (P ¼ 0.498), with TASC type C or D lesions in
106 (83%) versus 23 (92%, P ¼ 0.371). Prior percuta-
neous target vessel intervention was more common in
the standard access group (39 [30%] versus 3 [12%],
P ¼ 0.056), with the difference mainly due to prior
balloon angioplasty (27 [21%] versus 1 [4%], P ¼
0.048) in comparison to stenting (12 [9%] versus 2
[8%], P ¼ 1.0). Such differences may have impacted
on failure and recurrence rates, as restenoses are typi-
cally at higher risk of failure and recurrence [21].
Procedural and Outcome Data
Standard access sites were employed to recanalize
the SFA occlusions by either intraluminal or subintimal
approach in most patients, with guidewires of increas-
ing aggressiveness, stiffness, and hydrophilicity. Short
and small diameter sheaths were used in case of ante-
grade femoral approach, whereas longer and larger
sheaths were employed for contralateral retrograde
femoral access. Specifically, an antegrade ipsilateral
femoral access, which is well known for its increased
support and torque control [22] was used overall in 19
(12.5%) limbs, without significant differences in the
standard access site versus retrograde popliteal access
(16 [12.6%] versus 3 [12.0%], respectively, P ¼ 1.0).
The popliteal artery was successfully punctured by
fluoroscopy in all cases, enabling in all limbs the
deployment of a short 4 Fr sheath. Then, standard
guidewires of increasing aggressiveness, stiffness and
hydrophilicity were used, supported by catheters or bal-
loons. In most cases of combined femoral and popliteal
access, long femoral sheaths were used with a contra-
lateral retrograde femoral access.
Procedural success was achieved in 92 out of 107
patients (86.0%) treated with a standard approach and
22 out of 23 patients (95.7%) treated with retrograde
popliteal access (total 114 out of 130 patients [87.7%])
and 112 out of 127 limbs (88.2%), and 24 out of 25
limbs (96.0%), respectively (total 136 out of 152 limbs
[89.5%]). No significant increase in early or long-term
adverse events was associated with retrograde popliteal
access (Table III). Notably, antegrade femoral access
was not associated with significant differences in suc-
cess rates (17 [89.5%] versus 117 [89.3%], P ¼ 1.0).
DISCUSSION
This study has three major implications: (a) standard
access sites for challenging occlusions of the SFA still
face a significant risk of failure; (b) using a retrograde
popliteal access as bail-out strategy significantly
increases success rates; (c) these benefits are not coun-
terbalanced by an unduly increase in adverse events,
including local access site bleeding.
Thanks to major advancements in techniques and
devices, endovascular therapy has gained momentum
and now challenges the traditional leading role of
bypass surgery in several patient subsets. However,
selected patients with extremely complex lesions still
fare better with bypass surgery, which has remarkably
high long-term patency rates, especially when autolo-
gous veins are employed. Nonetheless, several patients
are not candidate to bypass surgery because of comor-
bidities, or prefer endovascular therapy despite being
thoroughly informed of the differences in risks and
benefits in comparison to surgery.
To further improve results of endovascular therapy
for lower limb atherosclerosis, improvements must
occur into two different realms: early success and
long-term patency. Although only medical therapy and
selected devices (e.g., stents) [23] are likely capable of
improving long-term patency rates, novel techniques
and dedicated devices are required to improve proce-
dural success rates. Recanalization attempts of SFA
occlusions are at high risk of failure when there are
difficulties in re-entering the true lumen after a long
subintimal track. In this case, dedicated re-entry devi-
ces have been proposed, such as the Outback (Cordis),
the Pioneer (Medtronic, Santa Rosa, CA), and the
TABLE III. Outcome Data
Standard access
(patients ¼ 107;
limbs ¼ 127)
Retrograde
popliteal access
(patients ¼ 23;
limbs ¼ 25) P value
In-hospital death 0 0 1.0
In-hospital major bleeding 2 (2%) 0 1.0
In-hospital groin hematoma 3 (3%) 0 1.0
Clinical follow-up duration
(months)
13  12 15  14 0.481
Death during follow-up 4 (4%) 1 (5%) 1.0
Rehospitalization during
follow-up
12 (25%) 2 (15%) 0.713
Bypass grafting during
follow-up
2 (2%) 1 (5%) 0.462
Amputation during
follow-up
1 (1%) 0 1.0
Fontaine class at
follow-up
0.519
I 40 (34%) 8 (36%)
II 7 (6%) 3 (14%)
III 5 (4%) 2 (9%)
IV 65 (56%) 9 (41%)
Primary patency 101 (80%) 21 (86%) 0.786
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SPOT System (Boston Scientific, Natick, MA)
[4,24,25]. However, their costs and requirements for
learning curve have limited their use so far.
The alternative to dedicated devices is a unique tech-
nique based on concomitant femoral and popliteal
access, which exploits the common presence of a
tapered distal stump of the SFA occlusion. This
approach, based on the use of 3 to 6 Fr sheaths (but
which can also be performed sheathless with a 0.01800
guidewire and compatible balloon) is applicable in all
but those patients with significant atherosclerotic
involvement of the popliteal artery.
Prior studies have already established the important
impact on success rates of concomitant femoral and
popliteal accesses, after the first pioneering descrip-
tion by Tonnesen et al. in 1988 [5,6,10–18,26]. In
particular, Henry et al. reported on 30 patients in
1993 in which popliteal access was associated with a
success rate of 80% [11]. Saha et al. described in
2001 the use of popliteal access in 38 limbs with ilio-
femoral lesions (including both stenoses and occlu-
sions), with final success in 97% [26], whereas in the
same year Yilmaz et al. provided data on 39 cases of
SFA occlusion, with successful recanalization in
82%.[12] In another large subset, Noory et al.
attempted retrograde popliteal access in 56 patients,
achieving a successful recanalization in 98%.[17]
However, none of these works explicitly compared
safety and efficacy of a combined femoral and popli-
teal access to a femoral only access.
Indeed, our work clearly builds upon previous works
on this topic, confirming that popliteal access signifi-
cantly increases success rates, achieving on average a
successful revascularization in 85–95% of patients. In
addition, our study provides further support to the
safety of the popliteal access, especially when puncture
is meticulously performed, in the absence of diseased
popliteal segments, and, in our opinion, without relying
on access closure devices [16,17]. From a technical
perspective, popliteal access can be obtained with fluo-
roscopic guidance or ultrasound guidance,[14] and with
the patient in a lateral or prone position. In addition, a
sheathless approach (with 0.01800 guidewires and suita-
ble balloons) can be chosen or, more commonly, a 3–6
Fr sheath. We recommend however, whenever possible,
to choose a prone position, puncture the artery under
fluoroscopic guidance with road mapping, and deploy a
4 Fr sheath to maximize support and minimize local
bleeding. Such a sheath enables the use of any guide-
wire, several balloons, and can be easily exchanged for
larger ones if stenting is attempted also retrogradely.
Conversely, hemostasis with a 4 Fr sheath is easily and
quickly achieved manually, thus reducing the risk of
local vessel complications.
Our work has several limitations, including the retro-
spective design, the obvious selection bias which
reflects the complex operators’ judgments and deci-
sions before and after retrograde popliteal access.
Indeed, the decision of using such approach was
altogether subjective, and several baseline patient and
lesion characteristics, such as prevalence of prior target
intervention, may bias the results again standard femo-
ral access. Accordingly and also given the differences
in size of the analyzed groups, statistical comparisons
should be viewed mainly as hypothesis generating.
Finally, occlusion stump shape, use of intraluminal
versus subintimal angioplasty, procedural time, and flu-
oroscopy time, despite being important to compare
standard and popliteal approaches, were not collected
in the study case report form and thus their analysis is
beyond the scope of our work.
CONCLUSIONS
Whenever standard accesses (i.e., femoral or brachial)
do not enable successful recanalization of SFA occlu-
sions, a retrograde popliteal access can be safely and
effectively envisioned as bail-out strategy.
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